Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001367644-25-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-04 | 2025-02-28+ | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $7.48 | -498 | 24.0K | -2% | -$3,725 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | F | D | 116 | $7.48 | 23,835 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |
| 2 | Common | Common Stock | 2025-02-28 | F | D | 382 | $7.48 | 23,951 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |